Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
P

Psybio Therapeutics Corp
OTC:PSYBF

Watchlist Manager
Psybio Therapeutics Corp
OTC:PSYBF
Watchlist
Price: 0 USD Market Closed
Market Cap: $0
Write Note Create Alert Ask AI

Bankruptcy Probability

Psybio Therapeutics Corp's probability of bankruptcy is 4.6%, pointing to a small but noticeable default risk. The solvency score is 34/100 — a warning sign of potential financial weakness.

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Moderate
Probability of Bankruptcy

Financial Position

Cash & Short-Term Investments
+
3Y
-
5Y
-
10Y
-
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
-
5Y
-
10Y
-

Solvency Ratios

Solvency Ratios Comparison
Psybio Therapeutics Corp Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
CA
Psybio Therapeutics Corp
OTC:PSYBF
943.1k USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
25.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Intra-Cellular Therapies Inc
F:23I
13B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Blueprint Medicines Corp
F:2L9
7.1B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Cidara Therapeutics Inc
F:20D0
5.4B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amicus Therapeutics Inc
F:AM6
3.8B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DE
MorphoSys AG
NASDAQ:MOR
2.9B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
SE
BioArctic AB
STO:BIOA B
26.6B SEK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CN
BGI Genomics Co Ltd
SZSE:300676
17.6B CNY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
SE
AddLife AB
STO:ALIF B
22.6B SEK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CN
Sino Biological Inc
SZSE:301047
13.7B CNY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue PSYBF Research

Summary
PSYBF intrinsic value, competitors valuation, and company profile.
DCF Valuation
PSYBF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PSYBF stock valuation using valuation multiples.
Wall St Estimates
PSYBF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PSYBF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Discover More
Is Psybio Therapeutics Corp at risk of bankruptcy?

Psybio Therapeutics Corp's probability of bankruptcy is 4.6%, pointing to a small but noticeable default risk.

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Psybio Therapeutics Corp have?

As of the latest report, Psybio Therapeutics Corp has no debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 361,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.